Amendements Apportés À La Version Précédente; Date De Publication - Leica BIOSYSTEMS NCL-g-SARC Mode D'emploi

11. Vainzof M, Moreira ES, Canovas M, et al. Partial alpha-sarcoglycan deficiency with retention of the dystrophin-glycoprotein complex
in a LGMD2D family. Muscle Nerve. 2000; 23(6):984–988.
12. Anderson LVB. Immunomarkers for molecular mass. Neuromuscular Disorders. 1999; 9(6-7):421–422.
13. Anderson LVB and Davison K. Multiplex Western blotting system for the analysis of muscular dystrophy proteins. American Journal of
Pathology. 1999; 154(4):1017–1022.
14. Sewry CA, Taylor J, Anderson LVB, et al. Abnormalities in alpha-, beta- and gamma-sarcoglycan in patients with limb-girdle muscular
dystrophy. Neuromuscular Disorders. 1996; 6(6):467–474.
15. Vainzof M, Passos-Bueno MR, Canovas M, et al. The sarcoglycan complex in the six autosomal recessive limb-girdle muscular
dystrophies. Human Molecular Genetics. 1996; 5(12):1963–1969.
16. Noguchi S, McNally EM Othmane KB, et al. Mutations in the dystrophin associated protein-gamma-sarcoglycan in chromosome 13
muscular dystrophy. Science 1995; 270:819–822.
Amendements Apportés à la Version Précédente
Utilisation Prévue, Mises en Garde et Précautions, Résultats Attendus.

Date de Publication

07 décembre 2018
G-SARC-CE
Page 9